Variant report
Variant | esv10799 |
---|---|
Chromosome Location | chr3:85878639-85884972 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CADM2-AS2 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543371356 | chr3:85878884-85878885 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs184500011 | chr3:85878912-85878913 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs188074692 | chr3:85878916-85878917 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs367756238 | chr3:85878932-85878933 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs532114736 | chr3:85878952-85878953 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs540215133 | chr3:85878956-85878957 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs376040652 | chr3:85884041-85884042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557601913 | chr3:85884051-85884052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138934911 | chr3:85884079-85884080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536600802 | chr3:85884082-85884083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186470486 | chr3:85884118-85884119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573701599 | chr3:85884120-85884121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189288654 | chr3:85884127-85884128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs13078807 | chr3:85884150-85884151 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
15 | rs578200664 | chr3:85884151-85884152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545740048 | chr3:85884153-85884154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544215243 | chr3:85884187-85884188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530945142 | chr3:85884188-85884189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs116020220 | chr3:85884198-85884199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181070748 | chr3:85884216-85884217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370538861 | chr3:85884230-85884231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114616854 | chr3:85884250-85884251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565568305 | chr3:85884261-85884262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532925662 | chr3:85884268-85884269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149411123 | chr3:85884305-85884306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185278960 | chr3:85884311-85884312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191331876 | chr3:85884314-85884315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374578695 | chr3:85884332-85884333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145764327 | chr3:85884348-85884349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73845687 | chr3:85884379-85884380 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs369669010 | chr3:85884464-85884465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs80094782 | chr3:85884479-85884480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79655202 | chr3:85884481-85884482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371945026 | chr3:85884493-85884494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77911417 | chr3:85884557-85884558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553075160 | chr3:85884609-85884610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs578227428 | chr3:85884684-85884685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539196739 | chr3:85884719-85884720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557689733 | chr3:85884746-85884747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575895892 | chr3:85884762-85884763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543299732 | chr3:85884839-85884840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377757726 | chr3:85884871-85884872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561161402 | chr3:85884902-85884903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573170934 | chr3:85884904-85884905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148309675 | chr3:85884914-85884915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs72114709 | chr3:85884915-85884916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs60751030 | chr3:85884926-85884927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Prostate cancer | 21307934 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:85884000-85884200 | Enhancers | Brain Hippocampus Middle | brain |
2 | chr3:85884200-85884800 | Weak transcription | Brain Hippocampus Middle | brain |
3 | chr3:85884800-85885400 | Enhancers | Brain Hippocampus Middle | brain |